[HTML][HTML] Automated paper screening for clinical reviews using large language models: Data analysis study
Background The systematic review of clinical research papers is a labor-intensive and time-
consuming process that often involves the screening of thousands of titles and abstracts …
consuming process that often involves the screening of thousands of titles and abstracts …
Drugs for COVID-19: An update
J Ceramella, D Iacopetta, MS Sinicropi, I Andreu… - Molecules, 2022 - mdpi.com
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was the seventh
known human coronavirus, and it was identified in Wuhan, Hubei province, China, in 2020. It …
known human coronavirus, and it was identified in Wuhan, Hubei province, China, in 2020. It …
Differential efficacy and safety of anti-SARS-CoV-2 antibody therapies for the management of COVID-19: a systematic review and network meta-analysis
Purpose To assess and compare the relative efficacy and safety of anti-SARS-CoV-2
antibody regimens for COVID-19. Methods This systematic review and random-effects …
antibody regimens for COVID-19. Methods This systematic review and random-effects …
An economically advantageous amorphous solid dispersion of the fixed combination of lopinavir and ritonavir
TS Yun, M Jung, KH Bang, HK Lee, M **… - Journal of …, 2023 - Springer
Purpose Solid dispersion strategies have recently been used to increase the solubility and
bioavailability of poorly soluble drugs. Among these various strategies for solid dispersion …
bioavailability of poorly soluble drugs. Among these various strategies for solid dispersion …
Synthesis and Biological Evaluation of Benzothiazolyl-pyridine Hybrids as New Antiviral Agents against H5N1 Bird Flu and SARS-COV-2 Viruses
A novel series of benzothiazolyl-pyridine hybrids 8a–h and 14a–e were produced from the
reaction of enamine derivative 4 with each of the arylcyanoacetamides 5a–h and …
reaction of enamine derivative 4 with each of the arylcyanoacetamides 5a–h and …
Inhibitors of SARS-CoV-2 main protease: Biological efficacy and toxicity aspects
The emergence of the highly contagious respiratory disease, COVID-19, caused by the
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has become a significant …
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has become a significant …
Will the use of pharmacogenetics improve treatment efficiency in COVID-19?
B Franczyk, J Rysz, J Miłoński, T Konecki… - Pharmaceuticals, 2022 - mdpi.com
The COVID-19 pandemic is associated with a global health crisis and the greatest challenge
for scientists and doctors. The virus causes severe acute respiratory syndrome with an …
for scientists and doctors. The virus causes severe acute respiratory syndrome with an …
Insights into COVID-19: Perspectives on Drug Remedies and Host Cell Responses
AM Awad, K Hansen, D Del Rio, D Flores… - Biomolecules, 2023 - mdpi.com
In light of the COVID-19 global pandemic caused by SARS-CoV-2, ongoing research has
centered on minimizing viral spread either by stop** viral entry or inhibiting viral …
centered on minimizing viral spread either by stop** viral entry or inhibiting viral …
Efficacy and safety of corticosteroid regimens for the treatment of hospitalized COVID-19 patients: a meta-analysis
Aim: To evaluate the efficacy and safety of corticosteroids for treating hospitalized COVID-19
patients. Materials & methods: Efficacy outcomes included time to negative SARS-CoV-2 …
patients. Materials & methods: Efficacy outcomes included time to negative SARS-CoV-2 …
Efficacy and safety of casirivimab and imdevimab for preventing and treating COVID-19: a systematic review and meta-analysis
Z Cui, H Wang, H Zou, L Li, Y Zhang… - Journal of Thoracic …, 2024 - pmc.ncbi.nlm.nih.gov
Background The ongoing global epidemic of coronavirus disease 2019 (COVID-19) has
created a serious public health problem. The selection of safe and effective therapeutic …
created a serious public health problem. The selection of safe and effective therapeutic …